Fluoride modulates formation and function of bone marrow macrophage-derived osteoclasts in a strain-specific manner

2016 ◽  
Author(s):  
Oliveira Flavia Amadeu de ◽  
Pereira Amanda Amaral ◽  
Silva Ventura Talita da ◽  
Buzalaf Marilia Afonso Rabelo ◽  
Oliveira Rodrigo Cardoso de ◽  
...  
2015 ◽  
Vol 128 (4) ◽  
pp. 683-694 ◽  
Author(s):  
T. W. Fowler ◽  
A. Kamalakar ◽  
N. S. Akel ◽  
R. C. Kurten ◽  
L. J. Suva ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 222-OR
Author(s):  
MICHAEL J. NASH ◽  
TAYLOR K. SODERBORG ◽  
RACHEL C. JANSSEN ◽  
ERIC M. PIETRAS ◽  
JACOB E. FRIEDMAN

Endocrinology ◽  
1998 ◽  
Vol 139 (4) ◽  
pp. 2092-2101 ◽  
Author(s):  
Katherine A. Kelly ◽  
Sakae Tanaka ◽  
Roland Baron ◽  
Jeffrey M. Gimble

2008 ◽  
Vol 13 (9) ◽  
pp. 587-587
Author(s):  
T. E. Scholzen ◽  
M. Fastrich ◽  
T. Brzoska ◽  
C. A. Armstrong ◽  
J. C. Ansel ◽  
...  

2007 ◽  
Vol 292 (1) ◽  
pp. H1-H18 ◽  
Author(s):  
Gina C. Schatteman ◽  
Martine Dunnwald ◽  
Chunhua Jiao

Over the past decade, the old idea that the bone marrow contains endothelial cell precursors has become an area of renewed interest. While some still believe that there are no endothelial precursors in the blood, even among those who do, there is no consensus as to what they are or what they do. In this review, we describe the problems in identifying endothelial cells and conclude that expression of endothelial nitric oxide synthase may be the most reliable antigenic indicator of the phenotype. The evidence for two different classes of endothelial precursors is also presented. We suggest that, though there is no single endothelial cell precursor, we may be able to use these phenotypic variations to our advantage in better understanding their biology. We also discuss how a variety of genetic, epigenetic, and methodological differences can account for the seemingly contradictory findings on the physiological relevance of bone marrow-derived precursors in normal vascular maintenance and in response to injury. Data on the impact of tumor type and location on the contribution of bone marrow-derived cells to the tumor vasculature are also presented. These data provide hope that we may ultimately be able to predict those tumors in which bone marrow-derived cells will have a significant contribution and design therapies accordingly. Finally, factors that regulate bone marrow cell recruitment to and function in the endothelium are beginning to be identified, and several of these, including stromal derived factor 1, monocyte chemoattractant factor-1, and vascular endothelial growth factor are discussed.


2021 ◽  
Vol 15 ◽  
Author(s):  
Yang Liu ◽  
Grace Hammel ◽  
Minjun Shi ◽  
Zhijian Cheng ◽  
Sandra Zivkovic ◽  
...  

Although the increased expression of members of the chondroitin sulfate proteoglycan family, such as neuron-glial antigen 2 (NG2), have been well documented after an injury to the spinal cord, a complete picture as to the cellular origins and function of this NG2 expression has yet to be made. Using a spinal cord injury (SCI) mouse model, we describe that some infiltrated bone marrow-derived macrophages (BMDMΦ) are early contributors to NG2/CSPG4 expression and secretion after SCI. We demonstrate for the first time that a lesion-related form of cellular debris generated from damaged myelin sheaths can increase NG2/CSPG4 expression in BMDMΦ, which then exhibit enhanced proliferation and decreased phagocytic capacity. These results suggest that BMDMΦ may play a much more nuanced role in secondary spinal cord injury than previously thought, including acting as early contributors to the NG2 component of the glial scar.


1989 ◽  
Vol 107 (6) ◽  
pp. 882-884
Author(s):  
A. A. Tsutsaeva ◽  
T. A. Glushko ◽  
L. E. Shatilova ◽  
N. G. Golubeva

Sign in / Sign up

Export Citation Format

Share Document